Aug 12, 2019 4:05 pm EDT VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update
Aug 8, 2019 8:30 am EDT Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer
Aug 7, 2019 8:45 am EDT VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update
Jul 24, 2019 4:05 pm EDT Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
Jul 18, 2019 8:30 am EDT VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
Jul 10, 2019 8:30 am EDT VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
May 8, 2019 4:05 pm EDT VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update
May 7, 2019 8:30 am EDT VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer
May 6, 2019 4:05 pm EDT VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update
Apr 9, 2019 5:17 pm EDT VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report
